Last week the Food and Drug Administration alerted healthcare providers of seven adverse events associated with steroid injections compounded at Main Street Family Pharmacy in Newbern, Tenn.
Further detail on the adverse events was not provided, but were all from patients who received preservative free methylprednisolone acetate (80 mg/mL) by injection, according to the FDA.
The FDA has recommended providers not administer any products from Main Street until further guidance is provided.
New Sterile Compounding Guidelines Released
Further detail on the adverse events was not provided, but were all from patients who received preservative free methylprednisolone acetate (80 mg/mL) by injection, according to the FDA.
The FDA has recommended providers not administer any products from Main Street until further guidance is provided.
More Articles on Compounding Pharmacy Contamination:
FDA Warns Drugs From Florida Compounding Shop May Be ContaminatedNew Sterile Compounding Guidelines Released